Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy, the brand-name semaglutide injection, was approved by the FDA in 2021 and became a breakthrough treatment for weight management. While Wegovy itself is only available as a weekly injection, patients seeking oral semaglutide tablets or compounded alternatives have other proven options. PlexusDx connects patients with licensed 503A compounding pharmacies that prepare both oral and injectable semaglutide formulations across all 50 states without insurance requirements.

What Is Wegovy and Why Is It Only an Injection?

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. The injectable form was chosen because semaglutide is a peptide hormone that breaks down quickly in stomach acid, making oral absorption challenging without special delivery technology. The once-weekly injection allows the medication to bypass digestive enzymes and enter the bloodstream directly, delivering consistent GLP-1 receptor activation over seven days.

The brand-name Wegovy comes in a prefilled pen delivering doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg weekly. Clinical trials showed that patients on the highest dose lost an average of 15% of body weight over 68 weeks compared to placebo. However, Wegovy's high out-of-pocket costs—often $900 to $1,500 per month without insurance—limited access for many patients seeking this therapy.

Oral Semaglutide Tablets: How They Overcome Digestion Barriers

Oral semaglutide tablets (Rybelsus®) use permeation enhancer technology that protects the peptide as it travels through the stomach and small intestine. This allows enough semaglutide to be absorbed through the intestinal wall to achieve therapeutic blood levels. Oral formulations typically require higher doses (7 mg, 10 mg, or 14 mg daily) compared to weekly injections because absorption is less efficient than direct injection.

PlexusDx offers compounded oral semaglutide starting at $289/mo (or $249/mo on the 6-month plan), providing a needle-free option for patients who prefer daily tablets. Oral tablets can be taken on an empty stomach with specific timing instructions to maximize absorption. For patients with needle anxiety or those who travel frequently, oral semaglutide simplifies medication management while delivering comparable weight loss outcomes to injectable forms.

Injection vs. Oral: Effectiveness, Absorption, and Patient Preferences

Research shows that injectable semaglutide achieves faster and more consistent blood concentrations than oral formulations because it enters circulation directly. Weekly injections typically reach steady-state levels in four to five weeks, while oral tablets require daily dosing to build therapeutic concentrations. For patients seeking rapid results or those with gastrointestinal conditions affecting absorption, injections may offer more predictable outcomes.

Oral semaglutide suits patients who prioritize convenience, needle avoidance, or medication discreetness. Daily dosing requires more discipline than a weekly injection, but many patients find tablets easier to incorporate into existing routines. PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan), offering cost flexibility alongside the oral $289/month option. Your provider can help match the form to your lifestyle, needle comfort level, and weight loss timeline.

Personalized Semaglutide Selection with Precision Peptide Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx maps 14 peptide pathways and 150+ genetic insights to guide medication selection and dosing strategy. The genetic test costs $99 as an add-on after your first month of treatment. Patients with favorable GLP1R variants may achieve faster weight loss, while those with genetic variations affecting the FTO gene (which regulates hunger) may benefit from higher-dose or combination therapies. This personalized approach removes guesswork from choosing between oral and injectable semaglutide forms.

Comparing Costs: Wegovy Brand vs. PlexusDx Compounded Options

Brand-name Wegovy typically costs $900 to $1,500 monthly without insurance, placing it beyond reach for many patients. PlexusDx compounded semaglutide injection begins at $189/mo (or $149/mo on the 6-month plan) and oral semaglutide at $289/mo (or $249/mo on the 6-month plan)—delivered to all 50 states without insurance requirements or membership fees. Both forms come from licensed 503A compounding pharmacies meeting pharmaceutical standards, offering medical-grade quality at a fraction of brand pricing.

PlexusDx medications are HSA and FSA eligible, allowing patients to use tax-advantaged health savings. Your dose may increase as your body adjusts, but your price remains flat—no surprise cost jumps based on dose escalation. For patients comparing Wegovy to PlexusDx options, the compounded alternatives provide access to the same active ingredient while removing financial barriers to consistent, long-term weight management therapy.

Side Effects and Safety Across Semaglutide Forms

Oral and injectable semaglutide carry similar side effect profiles because they activate the same GLP-1 receptors. Common effects include nausea, vomiting, diarrhea, and constipation during the first two to four weeks as the body adapts. GLP-1 side effects typically diminish as treatment continues, and dose escalation occurs gradually to allow tolerance to build.

Injectable semaglutide may cause mild injection-site reactions (redness, soreness) that resolve within hours. Oral semaglutide occasionally causes mild heartburn or reflux if not taken correctly on an empty stomach. Both forms share serious but rare risks including pancreatitis, severe gallbladder disease, and thyroid concerns in patients with personal or family history of medullary thyroid cancer. PlexusDx partners with licensed compounding pharmacies and medical providers to monitor safety and manage side effects throughout your treatment journey.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy available as a pill or only as an injection?

Wegovy brand-name semaglutide is only available as a weekly injection. However, oral semaglutide tablets exist (Rybelsus®) as a prescription alternative, and PlexusDx offers compounded oral semaglutide starting at $289/mo (or $249/mo on the 6-month plan) for patients preferring a needle-free form.

Which works better—injectable or oral semaglutide for weight loss?

Injectable semaglutide achieves faster blood concentration and may produce slightly faster initial weight loss, while oral semaglutide delivers comparable long-term results with better convenience. PlexusDx Precision Peptide Genetic Testing can identify which form suits your specific genetic metabolism and GLP-1 pathway responsiveness.

How much does PlexusDx compounded semaglutide cost compared to Wegovy?

Wegovy typically costs $900–$1,500/month without insurance. PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) and oral semaglutide at $289/mo (or $249/mo on the 6-month plan). Your dose may go up, but your price won't. Both are HSA/FSA eligible and available in all 50 states without insurance requirements.

Can I switch between oral semaglutide and injection during treatment?

Yes, many patients switch forms based on lifestyle changes, side effects, or response patterns. Your PlexusDx provider can guide dose conversion and monitor your transition. Some patients benefit from starting with one form and adjusting to another as their weight loss progresses and tolerance stabilizes.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves